Heghine Khachatryan: Honored to Be Part of The WFH Regional Workshop 2025
Heghine Khachatryan, Head of Hemophilia and Thrombosis Center, Yeolyan Hematology and Oncology Center, recently shared an honoring post on LinkedIn:
”Honored to be part of the World Federation of Hemophilia (WFH) regional workshop held in Istanbul, August 2025, hosted at the Sheraton City Center.
The event brought together an inspiring community of clinicians, patient leaders, and public health experts from across the globe to discuss ‘Hemophilia Care in the 21st Century: Updates on Diagnosis and Management.’
Through collaborative exchange and shared experiences, we reaffirmed our commitment to advancing comprehensive hemophilia care, improving access to treatment, and strengthening global partnerships in the bleeding disorders community.
Grateful to WFH for this impactful initiative, and to all the participants for their dedication and insight!”
Stay updated on the waves in the field of hemophilia with Hemostasis Today.
-
Jul 3, 2026, 05:55New Evidence Supports Chromogenic Assays After Hemophilia A Gene Therapy – JTH
-
Jul 3, 2026, 05:50Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
-
Jul 3, 2026, 05:25Brian A Beh: A New Approach from The George Institute for Global Health Could Transform Stroke Care Before Hospital Arrival
-
Jul 3, 2026, 05:22Deirdre Finnigan: New Insights into Red Blood Cell Biomechanics in Cancer-Associated Anemia
-
Jul 3, 2026, 05:15Danielle Boyle: Collaboration Across Borders Is Helping Shape the Future of ITP Care
-
Jul 3, 2026, 05:05Claire McIvor: One Year at the Stroke Association and Grateful for a Workplace That Made It Possible
-
Jul 2, 2026, 23:11Michael Makris: Join The Cancer Associated Thrombosis Workshop at ISTH 2026
-
Jul 2, 2026, 21:54Rob Maloney: Rare Disease Requires Relational Care
-
Jul 2, 2026, 21:53Quintijn Bonnez: How ADAMTS13 Conformation May Predict Early Relapse and Guide Pre-Emptive Therapy